Actively Recruiting
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Led by The Cooper Health System · Updated on 2024-06-10
400
Participants Needed
1
Research Sites
1148 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to follow the treatment options offered to pregnant women diagnosed with cancer and study the impact that their treatment or delay of treatment has on their own health and that of their children.
CONDITIONS
Official Title
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Database for Maternal, Fetal, and Neonatal Outcomes
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women diagnosed with cancer within 6 weeks before their last menstrual period or during pregnancy up to 6 months after delivery or miscarriage
You will not qualify if you...
- Women diagnosed with cancer more than 6 months after the end of a pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cooper University Hospital
Camden, New Jersey, United States, 08103
Actively Recruiting
Research Team
E
Elyce H Cardonick, MD
CONTACT
H
Harry Mazurek
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here